Navigation Links
Statement of HDMA President and CEO John M. Gray on the Importation of Prescription Drugs
Date:12/9/2009

ARLINGTON, Va., Dec. 9 /PRNewswire-USNewswire/ -- John M. Gray, President and Chief Executive Officer of the Healthcare Distribution Management Association (HDMA), issued the following statement in reaction to Senate Amendment 2793 to the Patient Protection and Affordable Care Act, which would allow for importation of prescription medications:

"Importation of prescription drugs from foreign countries, as Senator Dorgan and others propose to allow, would compromise the secure U.S. distribution system by increasing the likelihood of entry for counterfeit or adulterated medicines. Efforts to sell counterfeit or adulterated medications produced overseas have become far more sophisticated in just the past few years. Rather than exposing U.S. patients to such risks, Congress should enhance the safety and security of the domestic supply chain through enactment of a uniform federal pedigree standard.

"We are very concerned about provisions in the legislation which call for implementation of a track-and-trace system by 2012. While this effort to address patient safety is well-intentioned, it is not aligned with industry capabilities, technological developments, or federal guidance on product serialization. States that have looked at track-and-trace issues in depth understand the complexity of such an undertaking. That is why the most aggressive time horizons established by states for track-and-trace implementation begin in 2015.

"HDMA and its members support the enhancement of pharmaceutical supply chain security through establishment of a uniform federal pedigree standard. This would facilitate the flow of prescription medicines between states and enable manufacturers, distributors, pharmacies, regulators and law enforcement to identify and prevent the entry of illicit products into our drug supply.

"Before opening our borders, a realistic, comprehensive approach is needed to counter these threats, facilitate interstate commerce and reconcile inconsistencies among the patchwork of state requirements currently in place. Importation is and will be an unsound policy until these issues are addressed."

To learn more about HDMA's position on importation, health reform and other issues, visit www.healthcaredistribution.org.

About HDMA
HDMA is the national association representing primary healthcare distributors, the vital link in the healthcare system. Each business day, HDMA member companies ensure that more than nine million prescription medicines and healthcare products are safely delivered to more than 165,000 pharmacies, hospitals, nursing homes, physician offices, clinics and others nationwide. HDMA and its members work daily to provide value and contain costs, saving the nation's healthcare system an estimated $32 billion per year. For more information, visit www.HealthcareDistribution.org.

SOURCE Healthcare Distribution Management Association


'/>"/>
SOURCE Healthcare Distribution Management Association
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Statement from AAHSA CEO Larry Minnix on the Failure of the Thune Amendment
2. Natural Products Association Issues Statement on DEAs Steroid Classification Action
3. AAHSA Statement on Passage of Bennet Health Reform Amendment
4. Natural Products Association Issues Statement on New Supplement Safety Campaign
5. Statement of Support: Strengthening Oral Health Care is Key Part of Health Reform
6. Democratic National Committee Chairman Tim Kaines Statement on the Senates Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation
7. Statement by the Scientific Advisory Board of the Patient Advocate Foundation/National Patient Advocate Foundation on Changes to the USPSTF Mammography Guidelines
8. Pelosi Statement on House Passage of Medicare Physician Payment Reform Act
9. Democratic National Committee Chairman Issues Statement Praising the Patient Protection and Affordable Care Act
10. Statement of Robert Greenstein, Executive Director, Center on Budget and Policy Priorities, on the New Senate Health Reform Bill
11. Pelosi Statement on Senate Health Insurance Reform Bill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... ... Coalition Duchenne, a Newport Beach, California based charity committed ... in the April 25 U.S. Food and Drug Administration advisory committee hearing on ... the Marriott Conference Center in Hyattsville, Maryland was attended by over than a ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Society for Assisted Reproductive ... are required to report in vitro fertilization (IVF) delivery rates to ... practice of assisted reproductive technologies in the United States. , This year, ...
(Date:4/29/2016)... ... 2016 , ... The number of chronically and seriously ill individuals is growing. ... an urgent need for highly skilled care managers and care coordinators. Care ... train and retain care managers, and enhance their skills. , Care Excellence ...
(Date:4/28/2016)... ... April 29, 2016 , ... Monthly subscription boxes are all the ... They recently reviewed the ZEN BOX , the aromatherapy subscription box. , ZEN ... oils (like lavender or frankincense) and one Zen Blend (like immune boost, sublime sleep ...
(Date:4/28/2016)... ... 2016 , ... Sanford Health’s work in cellular therapy and ... and leaders from Sanford Health were selected to participate in the “ Third ... and receive the 2016 Pontifical Key Innovation Award at the Vatican. , The ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016 ... H1 2016" is a report that provides an ... strengthen R&D pipelines by identifying new targets and ... Company Profiles discussed in this H1 2016 ... Riunite Srl, AbbVie Inc., Abiogen Pharma S.p.A., Ablynx ...
(Date:4/27/2016)... le 27 Avril 2016 ... progressé de +5% sur le trimestre, soutenu par ... consommables  Croissance de +16% des ventes ... Mauna Kea Technologies (Euronext : MKEA, FR0010609263 ; OTCQX : ... laser, annonce aujourd,hui son chiffre d,affaires pour le ...
(Date:4/27/2016)... Transparency Market Research has published ... Global Industry Analysis, Size, Share, Growth, Trends, and Forecast ... skincare devices market was valued at US$ 7,255.8 Mn ... CAGR of 10.1% from 2015 to 2023 to reach ... full Skincare Devices Market (Treatment Device - LED Therapy Devices, ...
Breaking Medicine Technology: